Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.7585
-0.0237 (-3.03%)
Sep 11, 2026, 12:05 PM EDT - Market open
Onconetix Revenue
Onconetix had revenue of $17.12K in the quarter ending June 30, 2026, a decrease of -83.92%. This brings the company's revenue in the last twelve months to $645.82K, down -51.33% year-over-year. In the year 2025, Onconetix had annual revenue of $815.37K, down -67.70%.
Revenue (ttm)
$645.82K
Revenue Growth
-51.33%
P/S Ratio
4.78
Revenue / Employee
$322,912
Employees
2
Market Cap
3.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 815.37K | -1.71M | -67.70% |
| Dec 31, 2024 | 2.52M | 2.47M | 4,217.31% |
| Dec 31, 2023 | 58.47K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| 60 Degrees Pharmaceuticals | 1.21M |
| SciSparc | 856.00K |
| GeoVax Labs | 852.28K |
| BioRestorative Therapies | 357.87K |
| Addex Therapeutics | 136.51K |
| Silo Pharma | 54.08K |
ONCO News
- 8 days ago - Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events - GlobeNewsWire
- 11 days ago - Onconetix Registration statement: Registration filing - Filings
- 25 days ago - Onconetix registers to sell 100M shares of common stock for holders - TheFly
- 4 weeks ago - Onconetix Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Onconetix Registration statement: Registration filing - Filings
- 5 weeks ago - Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - GlobeNewsWire
- 5 weeks ago - Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - GlobeNewsWire
- 2 months ago - Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation - GlobeNewsWire